GlassScriptPhysician profile
Rachel Onorato
NPI 1750810834
$6,054.40
in general payments reported to CMS, 2019-2025
47 companies · $871 in 2025
The $871 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $948 · 2022: $1,339 · 2023: $1,591 · 2024: $1,305 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,757 · Education: $10.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,757.00 |
| Education | $10.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,075.16 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $929.15 | 2021-2025 | |
| Lilly USA, LLC | $569.46 | 2022-2025 | Jardiance, Mounjaro, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $431.14 | 2021-2025 | Jardiance, Ofev, Synjardy |
| Dexcom, INC. | $320.72 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Amarin Pharma, INC. | $320.46 | 2021-2023 | |
| Glaxosmithkline, LLC. | $255.18 | 2021-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $190.27 | 2021-2024 | Farxiga, Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $178.67 | 2021-2022 | |
| Seqirus USA INC | $148.61 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Astellas Pharma US INC | $132.59 | 2022-2025 | Veozah |
| Antares Pharma, INC. | $116.55 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Esperion Therapeutics, INC. | $113.77 | 2021-2024 | Nexletol |
| Azurity Pharmaceuticals, INC. | $97.78 | 2023-2025 | Azmiro, Horizant, Horizant |
| Janssen Pharmaceuticals, INC | $96.06 | 2021-2024 | Spravato |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $84.83 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $83.13 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $64.20 | 2021-2025 | Zoryve |
| Genentech USA, INC. | $63.15 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $59.88 | 2021-2022 | |
| Exact Sciences Corporation | $59.42 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.39 | 2024-2025 | Xifaxan |
| Pfizer INC. | $44.31 | 2023-2025 | |
| Abbott Laboratories | $40.17 | 2022 | |
| Axsome Therapeutics, INC. | $39.63 | 2024 | Auvelity |
| Avvisto Therapeutics, LLC | $37.84 | 2025 | Cycloset |
| Phathom Pharmaceuticals, INC. | $37.58 | 2024 | Voquezna |
| Renalytix Ai, INC. | $31.68 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Coloplast Corp | $29.56 | 2021 | |
| Althera Pharmaceuticals LLC | $29.32 | 2022 | |
| Sanofi-Aventis U.S. LLC | $26.71 | 2021 | |
| Si-Bone, INC. | $25.92 | 2025 | |
| Inari Medical, INC. | $25.56 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $23.43 | 2023 | Ffrct |
| Xeris Pharmaceuticals, INC. | $23.30 | 2023 | Keveyis |
| Biogen, INC. | $22.77 | 2021 | |
| Dynavax Technologies Corporation | $21.35 | 2023 | Heplisav-B |
| Tempus Ai, INC | $18.82 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $17.35 | 2024 | Crysvita |
| Aimmune Therapeutics, INC. | $16.67 | 2024 | |
| Tolmar, INC. | $15.96 | 2025 | Jatenzo |
| Nevro Corp. | $15.83 | 2023 | Senza |
| Eisai INC. | $15.43 | 2021 | |
| Madrigal Pharmaceuticals | $14.98 | 2025 | Rezdiffra |
| Halozyme INC | $14.14 | 2023 | |
| Alfasigma USA, INC. | $13.79 | 2021 | |
| Currax Pharmaceuticals LLC | $13.73 | 2023 | Contrave, Onzetra Xsail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Onorato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.